Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis (vol 74, pg AB244, 2016)

被引：0
|
作者：
Tan, H.
Valdez, H.
Griffiths, C.
Mrowietz, U.
Tallman, A. M.
Wolk, R.
Gordon, K. B.
机构：
来源：
JOURNAL OF DERMATOLOGICAL TREATMENT | 2017年 / 28卷 / 01期
关键词：
D O I：
10.1080/09546634.2016.1245484
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：X / X
页数：1
相关论文
共 50 条
  • [1] Early clinical response to tofacitinib treatment as a predictor of subsequent efficacy: Results from two phase 3 studies of patients with moderate-to-severe plaque psoriasis
    Tan, Huaming
    Valdez, Hernan
    Griffiths, Chris E. M.
    Mrowietz, Ulrich
    Tallman, Anna
    Wolk, Robert
    Gordon, Kenneth
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2017, 28 (01) : 3 - 7
  • [2] Early clinical response as a predictor of subsequent response to tofacitinib treatment: Results from two phase 3 studies of subjects with moderate to severe plaque psoriasis
    Tan, Huaming
    Valdez, Hernan
    Wolk, Robert
    Tallman, Anna
    Gordon, Kenneth B.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB244 - AB244
  • [3] Early clinical response as a predictor of subsequent response to ixekizumab treatment: results from a phase II study of patients with moderate-to-severe plaque psoriasis
    Zhu, B.
    Edson-Heredia, E.
    Cameron, G. S.
    Shen, W.
    Erickson, J.
    Shrom, D.
    Wang, P.
    Banerjee, S.
    Gordon, K. B.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (06) : 1337 - 1341
  • [4] Efficacy of tofacitinib for the treatment of nail psoriasis: Two 52-week, randomized, controlled phase 3 studies in patients with moderate-to-severe plaque psoriasis
    Merola, Joseph F.
    Elewski, Boni
    Tatulych, Svitlana
    Lan, Shuping
    Tallman, Anna
    Kaur, Mandeep
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (01) : 79 - +
  • [5] Efficacy of Tofacitinib for the Treatment of Moderate-to-Severe Chronic Plaque Psoriasis in Patient Subgroups from Two Randomised Phase 3 Trials
    Menter, M. Alan
    Papp, Kim A.
    Cather, Jennifer
    Leonardi, Craig
    Pariser, David M.
    Krueger, James G.
    Wohlrab, Johannes
    Amaya-Guerra, Mario
    Kaszuba, Andrzej
    Nadashkevich, Oleg
    Tsai, Tsen-Fang
    Gupta, Pankaj
    Tan, Huaming
    Valdez, Hernan
    Mallbris, Lotus
    Tatulych, Svitlana
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2016, 15 (05) : 568 - 580
  • [6] Efficacy of tofacitinib for the treatment of nail psoriasis: two 52-week Phase 3 studies in patients with moderate to severe plaque psoriasis
    Kaur, M.
    Merola, J.
    Tatulych, S.
    Mamolo, C.
    Lan, S.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2016, 30 : 81 - 81
  • [7] Efficacy of tofacitinib for the treatment of nail psoriasis: two 52-week phase 3 studies in patients with moderate to severe plaque psoriasis
    Merola, Joseph
    Tatulych, Svitlana
    Kaur, Mandeep
    Lan, Shuping
    Mallbris, Lotus
    Mamolo, Carla
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2015, 135 : S9 - S9
  • [8] Efficacy of tofacitinib for the treatment of nail psoriasis: Two 52-week phase 3 studies in patients with moderate to severe plaque psoriasis
    Merola, Joseph
    Tatulych, Svitlana
    Mamolo, Carla
    Lan, Shuping
    Mallbris, Lotus
    Kaur, Mandeep
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB248 - AB248
  • [9] Early clinical response as a predictor of efficacy in moderate to severe psoriasis patients treated with tofacitinib in a phase 2 study
    Gordon, Kenneth
    Strober, Bruce
    Tan, Huaming
    Yang, Lingfeng
    Wolk, Robert
    Mallbris, Lotus
    Valdez, Hernan
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB231 - AB231
  • [10] Two phase 3 studies of oral tofacitinib in patients with moderate to severe plaque psoriasis: 16-week efficacy and safety results
    Papp, Kim A.
    Menter, Martin A.
    Abe, Masatoshi
    Elewski, Boni E.
    Feldman, Steven R.
    Gottlieb, Alice G.
    Thaci, Diamant
    Luger, Thomas
    Tatulych, Svitlana
    Gupta, Pankaj
    Proulx, James
    Lan, Shu-Ping
    Wolk, Robert
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB66 - AB66
12345